Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy.

Nabulsi NA, Martin MT, Sharp LK, Koren DE, Teply R, Zuckerman A, Lee TA

Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire.

Mastroianni J, Thompson JA, Shifren JL, Zuckerman AL, Pereira K

Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist.

Banks AM, Peter ME, Holder GM, Jolly JA, Markley BM, Zuckerman SL, Choi L, Nwosu S, Zuckerman AD

Changes in Hippocampal Androgen Receptor Density and Behavior in Sprague-Dawley Male Rats Exposed to a Low-Pressure Blast Wave.

Hoffman JR, Zuckerman A, Ram O, Sadot O, Cohen H

Pharmacist Interventions to Improve Specialty Medication Adherence: Study Protocol for a Randomized Controlled Trial.

Kibbons AM, Peter M, DeClercq J, Choi L, Bell J, Jolly J, Cherry E, Alhashemi B, Shah NB, Zuckerman AD

Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non-small cell lung cancer: An integrated specialty pharmacy initiative.

Crothers G, Shah NB, Kim M, Zuckerman AD

Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States.

Rathbun RC, Durham SH, Farmer KC, Zuckerman AD, Badowski ME

Screening for Anxiety in Adolescent and Adult Women: A Recommendation From the Women's Preventive Services Initiative.

Gregory KD, Chelmow D, Nelson HD, Van Niel MS, Conry JA, Garcia F, Kendig SM, O'Reilly N, Qaseem A, Ramos D, Salganicoff A, Son S, Wood JK, Zahn C, Women’s Preventive Services Initiative

Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.

Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, Montine TJ, Poston KL, Andreasson KI

Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.

Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu DB, Schwartz D, Horst SN

Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis.

Moore E, Kelly SG, Alexander L, Luther P, Cooper R, Rebeiro PF, Zuckerman AD, Hargreaves M, Bourgi K, Schlundt D, Bonnet K, Pettit AC

An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities.

Zuckerman AD, Carver A, Cooper K, Markley B, Mitchell A, Reynolds VW, Saknini M, Wyatt H, Kelley T

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?

Zuckerman AD, Douglas A, Whelchel K, Choi L, DeClercq J, Chastain CA

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.

Davey RT Jr, FernĂĄndez-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD, INSIGHT FLU-IVIG Study Group

Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.

Paolella D, Cherry E, Jolly JA, DeClercq J, Choi L, Zuckerman A